Literature DB >> 27163984

Quantifying the Benefits and Risks of Methylphenidate as Treatment for Childhood Attention-Deficit/Hyperactivity Disorder.

Philip Shaw1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27163984     DOI： 10.1001/jama.2016.3427

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  Risks and Benefits of Attention-Deficit/Hyperactivity Disorder Medication on Behavioral and Neuropsychiatric Outcomes: A Qualitative Review of Pharmacoepidemiology Studies Using Linked Prescription Databases.

Authors:  Zheng Chang; Laura Ghirardi; Patrick D Quinn; Philip Asherson; Brian M D'Onofrio; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2019-04-17       Impact factor: 13.382

2.  ADHD Medication and Substance-Related Problems.

Authors:  Patrick D Quinn; Zheng Chang; Kwan Hur; Robert D Gibbons; Benjamin B Lahey; Martin E Rickert; Arvid Sjölander; Paul Lichtenstein; Henrik Larsson; Brian M D'Onofrio
Journal:  Am J Psychiatry       Date:  2017-06-29       Impact factor: 18.112

Review 3.  Treatment strategies for ADHD: an evidence-based guide to select optimal treatment.

Authors:  Arthur Caye; James M Swanson; David Coghill; Luis Augusto Rohde
Journal:  Mol Psychiatry       Date:  2018-06-28       Impact factor: 15.992

4.  The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.

Authors:  Kim Boesen; Luis Carlos Saiz; Juan Erviti; Ole Jakob Storebø; Christian Gluud; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Evid Based Med       Date:  2017-07-13

5.  Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea.

Authors:  Jimyung Park; Dong Yun Lee; Chungsoo Kim; Yo Han Lee; Su-Jin Yang; Sangha Lee; Seong-Ju Kim; Jeewon Lee; Rae Woong Park; Yunmi Shin
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2022-10-11       Impact factor: 7.494

6.  Attention-deficit/hyperactivity disorder medication and seizures.

Authors:  Kelsey K Wiggs; Zheng Chang; Patrick D Quinn; Kwan Hur; Robert Gibbons; David Dunn; Isabell Brikell; Henrik Larsson; Brian M D'Onofrio
Journal:  Neurology       Date:  2018-02-23       Impact factor: 9.910
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.